celecoxib/diacerein
/ Cadila
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
February 13, 2016
Cyclophosphamide With or Without Celecoxib in Treating Patients With Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer
(clinicaltrials.gov)
- P2; N=27; Active, not recruiting; Sponsor: City of Hope Medical Center; Trial primary completion date: Apr 2016 ➔ Jul 2018
Trial primary completion date • Biosimilar • Oncology • Ovarian Cancer
1 to 1
Of
1
Go to page
1